27252680|t|Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines.
27252680|a|The post-translational modification of proteins by O-linked beta-N-acetylglucosamine (O-GlcNAc) is regulated by a unique couple of enzymes. O-GlcNAc transferase (OGT) transfers the GlcNAc residue from UDP-GlcNAc, the final product of the hexosamine biosynthetic pathway (HBP), whereas O-GlcNAcase (OGA) removes it. This study and others show that OGT and O-GlcNAcylation levels are increased in cancer cell lines. In that context, we studied the effect of OGT silencing in the colon cancer cell lines HT29 and HCT116 and the primary colon cell line CCD841CoN. Herein, we report that OGT silencing diminished proliferation, in vitro cell survival and adhesion of primary and cancer cell lines. SiOGT dramatically decreased HT29 and CCD841CoN migration, CCD841CoN harboring high capabilities of migration in Boyden chamber system when compared to HT29 and HCT116. The expression levels of actin and tubulin were unaffected by OGT knockdown but siOGT seemed to disorganize microfilament, microtubule, and vinculin networks in CCD841CoN. While cancer cell lines harbor higher levels of OGT and O-GlcNAcylation to fulfill their proliferative and migratory properties, in agreement with their higher consumption of HBP main substrates glucose and glutamine, our data demonstrate that OGT expression is not only necessary for the biological properties of cancer cell lines but also for normal cells. 
27252680	103	109	Cancer	Disease	MESH:D009369
27252680	120	125	Human	Species	9606
27252680	230	238	O-GlcNAc	Gene	8473
27252680	284	304	O-GlcNAc transferase	Gene	8473
27252680	306	309	OGT	Gene	8473
27252680	325	331	GlcNAc	Chemical	MESH:D000117
27252680	345	355	UDP-GlcNAc	Chemical	-
27252680	382	392	hexosamine	Chemical	MESH:D006595
27252680	429	440	O-GlcNAcase	Gene	10724
27252680	442	445	OGA	Gene	10724
27252680	491	494	OGT	Gene	8473
27252680	539	545	cancer	Disease	MESH:D009369
27252680	600	603	OGT	Gene	8473
27252680	621	633	colon cancer	Disease	MESH:D015179
27252680	645	649	HT29	CellLine	CVCL:0320
27252680	654	660	HCT116	CellLine	CVCL:0291
27252680	693	703	CCD841CoN.	CellLine	CVCL:2871
27252680	727	730	OGT	Gene	8473
27252680	818	824	cancer	Disease	MESH:D009369
27252680	866	870	HT29	CellLine	CVCL:0320
27252680	989	993	HT29	CellLine	CVCL:0320
27252680	998	1004	HCT116	CellLine	CVCL:0291
27252680	1068	1071	OGT	Gene	8473
27252680	1146	1154	vinculin	Gene	7414
27252680	1167	1177	CCD841CoN.	CellLine	CVCL:2871
27252680	1184	1190	cancer	Disease	MESH:D009369
27252680	1226	1229	OGT	Gene	8473
27252680	1373	1380	glucose	Chemical	MESH:D005947
27252680	1385	1394	glutamine	Chemical	MESH:D005973
27252680	1422	1425	OGT	Gene	8473
27252680	1492	1498	cancer	Disease	MESH:D009369
27252680	Association	MESH:D005947	MESH:D009369
27252680	Association	MESH:D005973	MESH:D009369
27252680	Association	MESH:D005973	8473
27252680	Association	MESH:D009369	8473

